|
Volumn 69, Issue 3, 2001, Pages 209-
|
Delivering full planned dose on time (PDOT) chemotherapy (CT) while lowering the incidence of febrile neutropenia (FN) hospitalizations: Initial results from a prospective study providing Filgrastim support to high risk breast cancer patients (BCP)
a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
|
EID: 1442353101
PISSN: 01676806
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|